SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stemwriter who wrote (127)8/3/1998 10:58:00 PM
From: Sam Lee   of 320
 
Aronex has enough money to keep going until about June 1999 which is well known. Thereafter, their primary value is their research. I had a prior post addressing this. They can't really do a secondary stock offering at this level. So they need something to get the price up to $8-$10 just in case a secondary is necessary and it may not be with the right deal. Incidentally, there are two companies interested but I don't know any details at all.Smart money sees a deal or the stock would be under $1-IMHO.That is all I know.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News